Autori: Rugo Hope S
| Naslov | Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 (Article) |
| Autori | Goel Shom Tan Antoinette R Rugo Hope S Aftimos Philippe Andric Zoran G  Beelen Andrew Paul Zhang Jingshan Yi John S Malik Rajesh K O'Shaughnessy Joyce
|
| Info | FUTURE ONCOLOGY, (2022), vol. 18 br. 33, str. 3701-3711 |
| Projekat | G1 Therapeutics; Eli Lilly; Merck; Pfizer; AstraZeneca; Ayala; Boehringer Ingelheim; Daiichi; Gilead; Lilly; Macrogenics; Novartis; OBI; Odonate; Polyphor; Roche; Seattle Genetics; Sermonix |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2). (Meeting Abstract) |
| Autori | Goel Shom O'Shaughnessy Joyce Tan Antoinette R Milev-Krastev Boris Rugo Hope S Aftimos Philippe Georges Yardley Denise A Andric Zoran G Wolfgang Curt Douglas Sorrentino Jessica Tao Wenli Beelen Andrew Paul Malik Rajesh K Jain Sarika
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. - |
| Projekat | G1 Therapeutics, Inc |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting (Review) |
| Autori | Hesketh Paul J Aapro Matti Jordan Karin Schwartzberg Lee Steven Bosnjak Snezana M Rugo Hope S |
| Info | BIOMED RESEARCH INTERNATIONAL, (2015), vol. br. , str. - |
| Projekat | Helsinn Healthcare, SA |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
